Magle Chemoswed Holding ABMagle Chemoswed Holding AB - ESG Rating & Company Profile powered by AI

Industry Group:Pharmaceuticals

The ESG assessment for Magle Chemoswed Holding AB indicates the company's reporting of the United Nations SDGs. If you work at Magle Chemoswed Holding AB and you wish to use your ESG aseessment, please get in touch. The assessment of Magle Chemoswed Holding AB was prepared by All Street Sevva using cutting edge machine learning.

Magle Chemoswed Holding AB in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 5.2; made up of an environmental score of 8.0, social score of 4.8 and governance score of 2.7.

SDG Transparency Score for Magle Chemoswed Holding AB 
Low
0 - 3

5.2

Medium Impact
4 - 6
High
7 - 10
Last Score Update: 2023-07-01
What drives the score for Magle Chemoswed Holding AB 
8.0

Environmental

4.8

Social

2.7

Governance

Detailed ESG Breakdown
SEVVA Platform offers unique drill down to the underlying sources powering the ratings. Break down your ESG analysis by 17 UN SDGs and 8 additional governance factors.

Peer Group Comparison

RankCompanySDG Transparency Score Performance
1Novartis AG
9.2
High
2Daiichi Sankyo Co Ltd
8.9
High
912Vivanza Biosciences Ltd
5.3
High
912ValiRx PLC
5.3
High
958Magle Chemoswed Holding AB
5.2
High
958Altimmune Inc
5.2
High
958Agios Pharmaceuticals Inc
5.2
High
.........
2749Xynomic Pharmaceuticals Holdings Inc
0.0
Low
2749Zyden Gentec Ltd
0.0
Low
.........
View the full peer group of 3273 companies on the SEVVA platformSign up for free
Peer Companies Benchmark
SEVVA Platform benchmarks each company against a peer group. View the full score distribution for peers by logging into SEVVA

Frequently Asked Questions

Does Magle Chemoswed Holding AB have an accelerator or VC vehicle to help deliver innovation?

LockedSign up for free to unlock

Does Magle Chemoswed Holding AB disclose current and historical energy intensity?

LockedSign up for free to unlock

Does Magle Chemoswed Holding AB report the average age of the workforce?

LockedSign up for free to unlock

Does Magle Chemoswed Holding AB reference operational or capital allocation in relation to climate change?

LockedSign up for free to unlock

Does Magle Chemoswed Holding AB disclose its ethnicity pay gap?

LockedSign up for free to unlock

Does Magle Chemoswed Holding AB disclose cybersecurity risks?

LockedSign up for free to unlock

Does Magle Chemoswed Holding AB offer flexible work?

LockedSign up for free to unlock

Does Magle Chemoswed Holding AB have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?

LockedSign up for free to unlock

Does Magle Chemoswed Holding AB disclose the number of employees in R&D functions?

LockedSign up for free to unlock

Does Magle Chemoswed Holding AB conduct supply chain audits?

LockedSign up for free to unlock

Does Magle Chemoswed Holding AB disclose incidents of non-compliance in relation to the health and safety impacts of products and services?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')

LockedSign up for free to unlock

Does Magle Chemoswed Holding AB conduct 360 degree staff reviews?

LockedSign up for free to unlock

Does Magle Chemoswed Holding AB disclose the individual responsible for D&I?

LockedSign up for free to unlock

Does Magle Chemoswed Holding AB disclose current and historical air emissions?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')

LockedSign up for free to unlock

Is executive remuneration linked to climate performance?

LockedSign up for free to unlock

Does the Board describe its role in the oversight of climate-related risks and opportunities?

LockedSign up for free to unlock

Does Magle Chemoswed Holding AB disclose current and / or historical scope 2 emissions?

LockedSign up for free to unlock

Does Magle Chemoswed Holding AB disclose water use targets?

LockedSign up for free to unlock

Does Magle Chemoswed Holding AB have careers partnerships with academic institutions?

LockedSign up for free to unlock

Did Magle Chemoswed Holding AB have a product recall in the last two years?

LockedSign up for free to unlock

Does Magle Chemoswed Holding AB disclose incidents of discrimination?

LockedSign up for free to unlock

Does Magle Chemoswed Holding AB allow for Work Councils/Collective Agreements to be formed?

LockedSign up for free to unlock

Has Magle Chemoswed Holding AB issued a profit warning in the past 24 months?

LockedSign up for free to unlock

Does Magle Chemoswed Holding AB disclose parental leave metrics?

LockedSign up for free to unlock

Does Magle Chemoswed Holding AB disclose climate scenario or pathway analysis?

LockedSign up for free to unlock

Does Magle Chemoswed Holding AB disclose current and / or historical scope 1 emissions?

LockedSign up for free to unlock

Are Operating Expesnses linked to emissions reduction?

LockedSign up for free to unlock

Does Magle Chemoswed Holding AB disclose the pay ratio of women to men?

LockedSign up for free to unlock

Does Magle Chemoswed Holding AB support suppliers with sustainability related research and development?

LockedSign up for free to unlock

Does Magle Chemoswed Holding AB disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?

LockedSign up for free to unlock

Does Magle Chemoswed Holding AB reflect climate-related risks in its financial statements?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')

LockedSign up for free to unlock

Is Magle Chemoswed Holding AB involved in embryonic stem cell research?

LockedSign up for free to unlock

Does Magle Chemoswed Holding AB disclose GHG and Air Emissions intensity?

LockedSign up for free to unlock

Does Magle Chemoswed Holding AB disclose its waste policy?

LockedSign up for free to unlock

Does Magle Chemoswed Holding AB report according to TCFD requirements?

LockedSign up for free to unlock

Does Magle Chemoswed Holding AB disclose its policies for bribery, corruption, whistle-blower, conflict of interest?

LockedSign up for free to unlock

Does Magle Chemoswed Holding AB disclose energy use targets?

LockedSign up for free to unlock

Does Magle Chemoswed Holding AB disclose its Renewable Energy targets?

Only SubscribersSubscription required

Are emissions metrics verified by STBi?

Only SubscribersSubscription required

Does Magle Chemoswed Holding AB have a policy relating to cyber security?

LockedSign up for free to unlock

Have a different question?

Potential Risks for Magle Chemoswed Holding AB
These potential risks are based on the size, segment and geographies of the company.

Magle Chemoswed Holding AB (publ) engages in the research, development, and manufacturing in the areas of pharmaceutical chemistry and pharmaceutical technology in Sweden. The company focuses on the process development and manufacture of active pharmaceutical ingredients (API); and research, development, and production of products in the areas of wound care and diagnostics with a focus on products based on degradable starch microspheres. Its APIs include Warfarin sodium products that are used as anticoagulants for multiple indications; Melperone hydrochloride, which is an antipsychotic agent; Isradipine, a calcium channel blocker used to treat hypertension; Amantadine sulfate that is used in the treatment of central nervous system disorders; and Benserazide hydrochloride, which is used in combination with L-Dopa in the treatment of Parkinson's disease. The company also offers medical devices for applications in the areas of advanced wound care, surgical and diagnostics, and drug delivery comprising EmboCept S, a microsphere based medical device used in vascular occlusion of liver and lung tumors; SmartGel, a non-allergenic hydrogel based on the company's unique microsphere technology; SmartPAN, a medical device for the detection of pancreatic fluid leakage during open or minimally invasive surgical procedures; and EmboCept M, a device for use in the treatment of benign prostatic hyperplasia. It serves companies in the pharmaceutical and medical device industry on a contract basis. The company was founded in 1944 and is headquartered in Malmö, Sweden. Magle Chemoswed Holding AB (publ) is a subsidiary of Magle AB.

Sorry!

Failed to process!